Yugen Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 8 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 41.83%
(FY 2022)
- Profit 72.71%
(FY 2022)
- Ebitda -44.17%
(FY 2022)
- Net Worth 85.17%
(FY 2022)
- Total Assets 15.84%
(FY 2022)
About Yugen Chemicals
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chirag Khanna and Sneh Lata serve as directors at the Company.
- CIN/LLPIN
U24304DL2017PTC310398
- Company No.
310398
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Yugen Chemicals Private Limited offer?
Yugen Chemicals Private Limited offers a wide range of products and services, including Flavours & Aromatics, Antioxidants, Coir and Agro Products, Natural Gum, Food Additive, Nutraceuticals & Dietary Supplements, Fitness Supplements, Cooking Spices and Masala, Masala Powder, Cardiovascular Drugs & Medication.
Who are the key members and board of directors at Yugen Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chirag Khanna  | Director | 11-Jan-2017 | Current |
| Sneh Lata | Director | 11-Jan-2017 | Current |
Financial Performance of Yugen Chemicals.
Yugen Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.83% increase. The company also saw a substantial improvement in profitability, with a 72.71% increase in profit. The company's net worth Soared by an impressive increase of 85.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yugen Chemicals?
Unlock access to Yugen Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yugen Chemicals?
Unlock and access historical data on people associated with Yugen Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yugen Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yugen Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
